Comments
Loading...
Enlivex Therapeutics (NASDAQ:ENLV) Stock, Earnings Estimates, EPS, And Revenue
Enlivex Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 26
EPS Estimate
$-0.150
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Enlivex Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Enlivex Therapeutics (ENLV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-03-29 | $-0.48 | $-0.28 | -71.4 % |
| Sep 2023 | 2023-11-09 | $-0.32 | $-0.39 | 17.9 % |
| Jun 2023 | 2023-09-01 | $-0.37 | $-0.46 | 1956.5 % |
| Mar 2023 | 2023-04-10 | $-0.39 | $-0.34 | -14.7 % |
Enlivex Therapeutics (ENLV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Enlivex Therapeutics (NASDAQ:ENLV) reporting earnings?
Enlivex Therapeutics (ENLV) is scheduled to report earnings on November 30, 2024. The last reported earnings were for reported on March 29, 2024 for Q4.
What were the latest earnings per share (EPS) for Enlivex Therapeutics (NASDAQ:ENLV)?
The Actual EPS was $-0.48, which missed the estimate of $-0.28.
What were Enlivex Therapeutics’s (NASDAQ:ENLV) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.